{"entity":{"type":"insider","cik":"0001633582","url":"/insider/0001633582","json_url":"/insider/0001633582.json","name":"Thiel Carsten","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2015-09-10","last":"2017-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Thiel Carsten","source":"filing","n_filings":12,"first_seen":"2015-09-10","last_seen":"2017-03-06"}],"transactions":[{"id":4392251,"accession":"0000899866-17-000056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-17-000056","line_url":"/filing/0000899866-17-000056#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54.0,"shares_display":"54","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":30143.0,"shares_owned_after_display":"30,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":4069550,"accession":"0000899866-17-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000067","line_url":"/filing/0000899866-17-000067#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3783.0,"shares_display":"3,783","price_per_share":131.01,"price_display":"131.01","price_state":"stated","total_value":495610.83,"total_display":"495,610.83","total_whole":"495,611","shares_owned_after":33860.0,"shares_owned_after_display":"33,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-06","scope":"insider"},{"id":4392241,"accession":"0000899866-17-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000056","line_url":"/filing/0000899866-17-000056#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71.0,"shares_display":"71","price_per_share":131.2,"price_display":"131.20","price_state":"stated","total_value":9315.2,"total_display":"9,315.20","total_whole":"9,315","shares_owned_after":30197.0,"shares_owned_after_display":"30,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4734362,"accession":"0000899866-17-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000026","line_url":"/filing/0000899866-17-000026#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165.0,"shares_display":"165","price_per_share":125.69,"price_display":"125.69","price_state":"stated","total_value":20738.85,"total_display":"20,738.85","total_whole":"20,739","shares_owned_after":30268.0,"shares_owned_after_display":"30,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider"},{"id":3158912,"accession":"0000899866-16-000393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000393","line_url":"/filing/0000899866-16-000393#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2308.0,"shares_display":"2,308","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":300040.0,"total_display":"300,040.00","total_whole":"300,040","shares_owned_after":30433.0,"shares_owned_after_display":"30,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-09","filed_date":"2016-12-13","scope":"insider"},{"id":2989007,"accession":"0000899866-16-000367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000367","line_url":"/filing/0000899866-16-000367#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4584.0,"shares_display":"4,584","price_per_share":120.28,"price_display":"120.28","price_state":"stated","total_value":551363.52,"total_display":"551,363.52","total_whole":"551,364","shares_owned_after":32741.0,"shares_owned_after_display":"32,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-14","filed_date":"2016-10-18","scope":"insider"},{"id":3108025,"accession":"0000899866-16-000365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000365","line_url":"/filing/0000899866-16-000365#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29.0,"shares_display":"29","price_per_share":122.41,"price_display":"122.41","price_state":"stated","total_value":3549.89,"total_display":"3,549.89","total_whole":"3,550","shares_owned_after":37325.0,"shares_owned_after_display":"37,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":2056369,"accession":"0000899866-16-000355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-16-000355","line_url":"/filing/0000899866-16-000355#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":129.0,"price_display":"129.00","price_state":"stated","total_value":387000.0,"total_display":"387,000.00","total_whole":"387,000","shares_owned_after":37354.0,"shares_owned_after_display":"37,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-14","scope":"insider"},{"id":2056367,"accession":"0000899866-16-000355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000355","line_url":"/filing/0000899866-16-000355#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225.0,"shares_display":"225","price_per_share":124.2,"price_display":"124.20","price_state":"stated","total_value":27945.0,"total_display":"27,945.00","total_whole":"27,945","shares_owned_after":40354.0,"shares_owned_after_display":"40,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-12","filed_date":"2016-09-14","scope":"insider"},{"id":2056363,"accession":"0000899866-16-000351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000351","line_url":"/filing/0000899866-16-000351#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":125.94,"price_display":"125.94","price_state":"stated","total_value":125940.0,"total_display":"125,940.00","total_whole":"125,940","shares_owned_after":40579.0,"shares_owned_after_display":"40,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-08","scope":"insider"},{"id":2719118,"accession":"0000899866-16-000273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-16-000273","line_url":"/filing/0000899866-16-000273#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54.0,"shares_display":"54","price_per_share":138.91,"price_display":"138.91","price_state":"stated","total_value":7501.14,"total_display":"7,501.14","total_whole":"7,501","shares_owned_after":41579.0,"shares_owned_after_display":"41,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-01","scope":"insider"},{"id":2641832,"accession":"0000899866-16-000252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000252","line_url":"/filing/0000899866-16-000252#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187.0,"shares_display":"187","price_per_share":143.49,"price_display":"143.49","price_state":"stated","total_value":26832.63,"total_display":"26,832.63","total_whole":"26,833","shares_owned_after":36633.0,"shares_owned_after_display":"36,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-16","filed_date":"2016-02-18","scope":"insider"},{"id":8170691,"accession":"0000899866-15-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000197","line_url":"/filing/0000899866-15-000197#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":173.34,"price_display":"173.34","price_state":"stated","total_value":520020.0,"total_display":"520,020.00","total_whole":"520,020","shares_owned_after":28018.0,"shares_owned_after_display":"28,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-11-12","scope":"insider"},{"id":8934731,"accession":"0000899866-15-000174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000174","line_url":"/filing/0000899866-15-000174","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001633582","owner_name":"Thiel Carsten","owner_display_name":"Thiel Carsten","owner_url":"/insider/0001633582","role":"Officer (SVP, EMEA & Asia Pacific)","role_mark":"O","role_mark_label":"Officer (SVP, EMEA & Asia Pacific)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, EMEA & Asia Pacific","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":812.0,"shares_display":"812","price_per_share":169.17556650246306,"price_display":"169.18","price_state":"stated","total_value":137370.56,"total_display":"137,370.56","total_whole":"137,371","shares_owned_after":29030.0,"shares_owned_after_display":"29,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (EVP, Chief Commercial Officer)","n_filings":12,"first_seen":"2015-09-10","last_seen":"2017-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001633582","retrieved_at":"2026-08-27T07:25:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}